Doctors in the US are running low on medication for cancer patients.
Supplies ran short after production was halted in India.
The US is allowing replacement supplies from China.
But Congress is being warned that American over-reliance on foreign suppliers is a security risk.
Al Jazeera’s Heidi Zhou-Castro reports from Washington, DC.
Subscribe to our channel http://bit.ly/AJSubscribe
Follow us on Twitter https://twitter.com/AJEnglish
Find us on Facebook https://www.facebook.com/aljazeera
Check our website: https://www.aljazeera.com/
Check out our Instagram page: https://www.instagram.com/aljazeeraenglish/
Download AJE Mobile App: https://aje.io/AJEMobile
#UnitedStates #CancerDrugs #CancerPatients #DrugShortage #Cisplatin #Carboplatin #PublicHealthCrisis #CancerCare #Chemotheraby
Comments
Comments are disabled for this post.